Literature DB >> 31201492

[Stimulation of fracture healing by growth factors and cell-based technologies].

J Everding1, J Stolberg-Stolberg1, M J Raschke1, R Stange2,3.   

Abstract

Bone has the special capability to completely regenerate after trauma and to re-establish its original geometry and biomechanical stability corresponding to the pretrauma conditions. Nevertheless, in daily clinical practice impaired fracture healing and nonunions are regular complications as a result of inadequate mechanical stability and/or insufficient biological processes around the fracture region. Since the beginning of the millennium, intensive research on the physiological processes in bone healing as well as the production and clinical administration of growth factors have enabled the possibility to improve the local biological processes during fracture healing by osteoinduction. Although the initial clinical results, particularly of bone morphogenetic proteins, in fracture healing were promising, growth factors did not become established for unrestricted use in the clinical application. Currently, additional growth factors are being investigated with respect to the potential supportive and osteoinductive characteristics for enhancement of fracture healing and possible clinical applications. Furthermore, the development of cell-based technologies is another promising approach to positively stimulate fracture healing. In addition to the gold standard of autologous bone grafting, harvesting of mesenchymal stroma cells by aspiration has gained in importance in recent years. Allogeneic bone cell transplantation procedures and in particular gene therapy are promising new strategies for the treatment of disorders of fracture healing. This review gives an overview of present and future possibilities for modulation of fracture healing by growth factors and cell-based technologies.

Entities:  

Keywords:  Bone morphogenetic proteins; Gene therapy; Mesenchymal stem cell transplantation; Non-unions; Osteogenesis

Mesh:

Substances:

Year:  2019        PMID: 31201492     DOI: 10.1007/s00113-019-0686-9

Source DB:  PubMed          Journal:  Unfallchirurg        ISSN: 0177-5537            Impact factor:   1.000


  37 in total

Review 1.  The role of growth factors in the repair of bone. Biology and clinical applications.

Authors:  Jay R Lieberman; Aaron Daluiski; Thomas A Einhorn
Journal:  J Bone Joint Surg Am       Date:  2002-06       Impact factor: 5.284

Review 2.  A review of preclinical program development for evaluating injectable carriers for osteogenic factors.

Authors:  Howard Seeherman; Rebecca Li; John Wozney
Journal:  J Bone Joint Surg Am       Date:  2003       Impact factor: 5.284

3.  Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells.

Authors:  Ph Hernigou; A Poignard; F Beaujean; H Rouard
Journal:  J Bone Joint Surg Am       Date:  2005-07       Impact factor: 5.284

4.  Quantitative assessment of growth factors in reaming aspirate, iliac crest, and platelet preparation.

Authors:  G Schmidmaier; S Herrmann; J Green; T Weber; A Scharfenberger; N P Haas; B Wildemann
Journal:  Bone       Date:  2006-07-25       Impact factor: 4.398

Review 5.  The role of growth factors and related agents in accelerating fracture healing.

Authors:  A H R W Simpson; L Mills; B Noble
Journal:  J Bone Joint Surg Br       Date:  2006-06

6.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.

Authors:  M Dominici; K Le Blanc; I Mueller; I Slaper-Cortenbach; Fc Marini; Ds Krause; Rj Deans; A Keating; Dj Prockop; Em Horwitz
Journal:  Cytotherapy       Date:  2006       Impact factor: 5.414

Review 7.  Fracture healing: the diamond concept.

Authors:  Peter V Giannoudis; Thomas A Einhorn; David Marsh
Journal:  Injury       Date:  2007-09       Impact factor: 2.586

8.  Acceleration of fracture healing in nonhuman primates by fibroblast growth factor-2.

Authors:  H Kawaguchi; K Nakamura; Y Tabata; Y Ikada; I Aoyama; J Anzai; T Nakamura; Y Hiyama; M Tamura
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

9.  Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions.

Authors:  G E Friedlaender; C R Perry; J D Cole; S D Cook; G Cierny; G F Muschler; G A Zych; J H Calhoun; A J LaForte; S Yin
Journal:  J Bone Joint Surg Am       Date:  2001       Impact factor: 5.284

10.  Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients.

Authors:  Shunmugam Govender; Cristina Csimma; Harry K Genant; Alexandre Valentin-Opran; Yehuda Amit; Ron Arbel; Hannu Aro; Dan Atar; Michael Bishay; Martin G Börner; Philippe Chiron; Peter Choong; John Cinats; Brett Courtenay; Robert Feibel; Bernard Geulette; Charles Gravel; Norbert Haas; M Raschke; Eric Hammacher; D van der Velde; Philippe Hardy; Michael Holt; Christof Josten; Rupert Ludwig Ketterl; Bennie Lindeque; Günter Lob; Henry Mathevon; Gerald McCoy; D Marsh; Russell Miller; Everard Munting; Stein Oevre; L Nordsletten; Amratlal Patel; Anthony Pohl; William Rennie; Peter Reynders; Pol Maria Rommens; Jean Rondia; Willem C Rossouw; P J Daneel; Stephen Ruff; Axel Rüter; Seppo Santavirta; Thomas A Schildhauer; C Gekle; Reinhard Schnettler; David Segal; Hanns Seiler; Robert B Snowdowne; Jouwert Stapert; Gilbert Taglang; Rene Verdonk; Lucas Vogels; Arnulf Weckbach; Andreas Wentzensen; Tadeusz Wisniewski
Journal:  J Bone Joint Surg Am       Date:  2002-12       Impact factor: 5.284

View more
  1 in total

1.  Addition of shock wave therapy to nail dynamization increases the chance of long-bone non-union healing.

Authors:  Josef Stolberg-Stolberg; Thomas Fuchs; Moritz F Lodde; Steffen Roßlenbroich; Patric Garcia; Michael Raschke; Jens Everding
Journal:  J Orthop Traumatol       Date:  2022-01-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.